SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022

Aug 9 2022
Steady Operational Performance Amidst Macroeconomic Headwinds BOSTON and LAUSANNE, Switzerland, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the second quarter ended June 30, 2022.

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Junior Sales Operations Specialist Intern France Clinical Sales
Junior Bioinformation Intern - Tertiary Analysis Switzerland Data Science
Junior Customer Services Specialist Intern Switzerland Clinical Sales
Accounts Payable Accountant France Finance
NGS Sales Manager - ANZ Australia Clinical Sales